Reg. 34 (1) Annual Report.
Filed with BSE · · 71 pages · English
Summary by 6ix AI
It includes details about the company's corporate information, board of directors, and the notice for the upcoming Annual General Meeting. The report outlines the financial highlights, state of company affairs, and proposed changes in director appointments. It also provides instructions for attending the AGM through video conferencing.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Scheme of Arrangement
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 25 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals